Covidien Ltd. (NYSE:COV)
The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
Recs
good company in healthcare sector
Recs
Covidian will underperform the S&P for the next year.
Recs
Without much debt to equity, Covidien is among the leaders in a sector that will likely outperform for the short to mid-term. The stock is a buck or two above the 50 day moving average here, but insiders were picking it up at $50+ in mid 08. Year over year revenue increased by 12%, and it's trading at a modest 12.75 forward p/e.
Recs
Recs
the new medtronic, 1/2 it's size, ready to heal all the boomers
Recs
Stock has been hammered. Part of "Tri-vestiture" from Tyco International (Tyco International split into Tyco Electronics, Covidien and Tyco International).
Recs
Revenues for this company have been expanding but earnings have lagged; 08 earnings of 2.56 should go to 2.89 or 13% increase in 09 over 08. Issue has been very stable and there's been consistent insider buying since IPO around Sept 07.
Recs
This stock was picked by TMFTerp in the 2008 TMF Stockpicking Contest.
Recs
Recs
This healthcare stock is just going to keep going up as the boomers age. I like the young group of executives running this company too.
Recs
The type of medical device that this company produce are needed by hospitals and other medical facilities. They are No. 1 in their field.
Recs
Great company with multiple product lines. This stock will outperform the S&P over the next year.
Recs
US Surgical, Kendall, Curity, all brand names maybe not on store shelves but definitely in hospitals the world over.
Recs
Great player in healthcare with strong product line, and development pipeline. Innovator and growing marketshare. As minially invasive surgery continues to grow with robotics as the next
"me to" must have this baby can only go UP! Might be sleeper of the year
Recs
Expanding business my taking share from JNJ in suture business because of discount pricing which is attractive to hospitals in this economy, and expanding into hernia mesh as well
Recs
great business, low p/e, unique managment, recently spun-off
Recs
This one hasn't taken off, but I think patience will be rewarded - eventually.
Recs
Lacking R&D and new product pipeline...long term = Bearish
Recs
the uptrend has caught my eye
Recs
found this one last nite 9/3/07... Healthcare has got to be good, right? It is in the middle of the 52 week range and all it needs is some good news to propel it higher

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 28 1 2 Next »